Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Sanjay, Pujari"'
Autor:
Valliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, Deepak Thangaraju, Manoj Radhakishan Shevkani, Atul K Patel, Prakash Srinivas Shastri, Ashwini Tayade, Sudhir Bhandari, Vishwanath Gella, Jayanthi Savio, Surabhi Madan, Vinaykumar Hallur, Venkata Nagarjuna Maturu, Arjun Srinivasan, Nandini Sethuraman, Raminder Pal Singh Sibia, Sanjay Pujari, Ravindra Mehta, Tanu Singhal, Puneet Saxena, Varsha Gupta, Vasant Nagvekar, Parikshit Prayag, Dharmesh Patel, Immaculata Xess, Pratik Savaj, Inderpaul Singh Sehgal, Naresh Panda, Gayathri Devi Rajagopal, Riya Sandeep Parwani, Kamlesh Patel, Anuradha Deshmukh, Aruna Vyas, Raghava Rao Gandra, Srinivas Kishore Sistla, Priyadarshini A Padaki, Dharshni Ramar, Manoj Kumar Panigrahi, Saurav Sarkar, Bharani Rachagulla, Pattabhiraman Vallandaramam, Krishna Prabha Premachandran, Sunil Pawar, Piyush Gugale, Pradeep Hosamani, Sunil Narayan Dutt, Satish Nair, Hariprasad Kalpakkam, Sanjiv Badhwar, Kiran Kumar Kompella, Nidhi Singla, Amrita Prayag, Gagandeep Singh, Poorvesh Dhakecha, Arunaloke Chakrabarti
Publikováno v:
Lung India, Vol 41, Iss 3, Pp 221-224 (2024)
Externí odkaz:
https://doaj.org/article/03f16e11cc6a400692c754cb836ace69
Autor:
Ki Hyun Lee, Awachana Jiamsakul, Sasisopin Kiertiburanakul, Rohidas Borse, Vohith Khol, Evy Yunihastuti, Iskandar Azwa, I Ketut Agus Somia, Romanee Chaiwarith, Thach Ngoc Pham, Suwimon Khusuwan, Cuong Duy Do, Nagalingeswaran Kumarasamy, Yasmin Gani, Rossana Ditangco, Oon Tek Ng, Sanjay Pujari, Man Po Lee, Anchalee Avihingsanon, Hsin-Pai Chen, Fujie Zhang, Junko Tanuma, Jeremy Ross, Jun Yong Choi
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0306245 (2024)
IntroductionToxoplasma gondii can cause symptomatic toxoplasmosis in immunodeficient hosts, including in people living with human immunodeficiency virus (PLWH), mainly because of the reactivation of latent infection. We assessed the prevalence of tox
Externí odkaz:
https://doaj.org/article/3ad7be75a16f440f969ef760afc82ae9
Autor:
Valliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, Deepak Thangaraju, Manoj Radhakishan Shevkani, Atul K. Patel, Prakash Srinivas Shastri, Ashwini Tayade, Sudhir Bhandari, Vishwanath Gella, Jayanthi Savio, Surabhi Madan, Vinay Kumar Hallur, Venkata Nagarjuna Maturu, Arjun Srinivasan, Nandini Sethuraman, Raminder Pal Singh Sibia, Sanjay Pujari, Ravindra Mehta, Tanu Singhal, Puneet Saxena, Varsha Gupta, Vasant Nagvekar, Parikshit Prayag, Dharmesh Patel, Immaculata Xess, Pratik Savaj, Naresh Panda, Gayathri Devi Rajagopal, Riya Sandeep Parwani, Kamlesh Patel, Anuradha Deshmukh, Aruna Vyas, Srinivas Kishore Sistla, Priyadarshini A Padaki, Dharshni Ramar, Saurav Sarkar, Bharani Rachagulla, Pattabhiraman Vallandaramam, Krishna Prabha Premachandran, Sunil Pawar, Piyush Gugale, Pradeep Hosamani, Sunil Narayan Dutt, Satish Nair, Hariprasad Kalpakkam, Sanjiv Badhwar, Kiran Kumar Kompella, Nidhi Singla, Milind Navlakhe, Amrita Prayag, Gagandeep Singh, Poorvesh Dhakecha, Arunaloke Chakrabarti
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 1, Pp 8-19 (2023)
We performed a case–control study across 25 hospitals in India for the period of January–June 2021 to evaluate the reasons for an COVID-19–associated mucormycosis (CAM) outbreak. We investigated whether COVID-19 treatment practices (glucocortic
Externí odkaz:
https://doaj.org/article/41f3e28728854b5da17b129767701ef8
Autor:
Jeremy Ross, Dhanushi Rupasinghe, Anchalee Avihingsanon, Man Po Lee, Sanjay Pujari, Gerald Sharp, Nagalingeswaran Kumarasamy, Suwimon Khusuwan, Vohith Khol, I Ketut Agus Somia, Thach Ngoc Pham, Sasisopin Kiertiburanakul, Jun Yong Choi, Cuong Duy Do, Annette H Sohn, Awachana Jiamsakul, TAHOD-LITE study group of IeDEA Asia‐Pacific
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0287909 (2023)
BackgroundChronic hepatitis C virus (HCV) infection contributes to substantial morbidity and mortality among adults living with HIV. Cascades of HCV care support monitoring of program performance, but data from Asia are limited. We assessed regional
Externí odkaz:
https://doaj.org/article/613d506c4fcb403ca97c3ab005fca696
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 3, Pp 1037-1043 (2021)
Abstract Background Long‐COVID is emerging as a significant problem among individuals who recovered from COVID‐19. Scant information is available on the prevalence, characteristics, and risk factors for long‐COVID among people living with HIV (
Externí odkaz:
https://doaj.org/article/b6a481f426d14239a4bba2cb51e36fe6
Autor:
Jung Ho Kim, Awachana Jiamsakul, Sasisopin Kiertiburanakul, Bui Vu Huy, Suwimon Khusuwan, Nagalingeswaran Kumarasamy, Oon Tek Ng, Penh Sun Ly, Man-Po Lee, Yu-Jiun Chan, Yasmin Mohamed Gani, Iskandar Azwa, Anchalee Avihingsanon, Tuti Parwati Merati, Sanjay Pujari, Romanee Chaiwarith, Fujie Zhang, Junko Tanuma, Cuong Duy Do, Rossana Ditangco, Evy Yunihastuti, Jeremy Ross, Jun Yong Choi, IeDEA Asia-Pacific
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0264157 (2022)
The use of holding regimens for people living with HIV (PLWH) without effective antiretroviral options can have effects on outcomes and future treatment options. We aimed to investigate the use of holding regimens for PLWH in Asian countries. Data fr
Externí odkaz:
https://doaj.org/article/3d1479ada5ce412dbcdab94a76ffd84b
Autor:
Neil Saldanha, Kiran Runwal, Charulata Ghanekar, Sunil Gaikwad, Shrivallabh Sane, Sanjay Pujari
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background Most studies assessing drug resistant tuberculosis (DRTB) in human immunodeficiency virus (HIV) co-infected patients in India have used conventional culture- based systems to diagnose DRTB that have a longer turnaround time leadin
Externí odkaz:
https://doaj.org/article/61ff1816297d44899377ae764da88d23
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 722- (2021)
Externí odkaz:
https://doaj.org/article/244be0a696ec4b2ca242c8c0cebba997
Publikováno v:
Journal of Pharmaceutical Negative Results. :3495-3499
The world is restoring life balance after the global Covid-19 pandemic. This situation, giving birth to new problems, arose as an outcome of pre-and post pandemic scenarios. Healthcare system was under tremendous burden during this pandemic. Governme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50a0b5aa07f55962f75a8018335a5a61
https://doi.org/10.47750/pnr.2022.13.s08.429
https://doi.org/10.47750/pnr.2022.13.s08.429
Autor:
Sasisopin Kiertiburanakul, David Boettiger, Oon Tek Ng, Nguyen Van Kinh, Tuti Parwati Merati, Anchalee Avihingsanon, Wing-Wai Wong, Man Po Lee, Romanee Chaiwarith, Adeeba Kamarulzaman, Pacharee Kantipong, Fujie Zhang, Jun Yong Choi, Nagalingeswaran Kumarasamy, Rossana Ditangco, Do Duy Cuong, Shinichi Oka, Benedict Lim Heng Sim, Winai Ratanasuwan, Penh Sun Ly, Evy Yunihastuti, Sanjay Pujari, Jeremy L. Ross, Matthew Law, Somnuek Sungkanuparph, on behalf of the TREAT Asia HIV Observational Databases (TAHOD)
Publikováno v:
AIDS Research and Therapy, Vol 14, Iss 1, Pp 1-8 (2017)
Abstract Background Abacavir and rilpivirine are alternative antiretroviral drugs for treatment-naïve HIV-infected patients. However, both drugs are only recommended for the patients who have pre-treatment HIV RNA 30 kg/m2 (OR 2.4 vs. 350 cells/mm3
Externí odkaz:
https://doaj.org/article/0f687c31cd6545d8ab9081cd198bdf01